Phase II Study of JNS024PR in Cancer Pain Patients

Trial Profile

Phase II Study of JNS024PR in Cancer Pain Patients

Phase of Trial: Phase II

Latest Information Update: 26 Jul 2013

At a glance

  • Drugs Tapentadol (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Janssen Pharmaceutical KK
  • Most Recent Events

    • 10 Oct 2009 Status changed from active, no longer recruiting to completed as reported by
    • 04 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by
    • 16 Jun 2009 Planned end date changed from May 2009 to Jul 2009 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top